Abstract:Small-diameter synthetic vascular grafts have high failure rate due to primarily surface thrombogenicity, and effective surface chemical modification is critical to maintain the patency of the grafts. In this study, we engineered a small-diameter, elastic synthetic vascular graft with off-the-shelf availability and antithrombogenic activity. Polycarbonate-urethane (PCU), was electrospun to produce nanofibrous grafts that closely mimicked a native blood vessel in terms of structural and mechanical strength. To overcome the difficulty of adding functional groups to PCU, we explored various surface modification methods, and determined that plasma treatment was the most effective method to modify the graft surface with functional amine groups, which were subsequently employed to conjugate heparin via end-point immobilization. In addition, we confirmed in vitro that the combination of plasma treatment and end-point immobilization of heparin exhibited the highest surface density and correspondingly the highest antithrombogenic activity of heparin molecules. Furthermore, from an in vivo study using a rat common carotid artery anastomosis model, we showed that plasma-heparin grafts had higher patency rate at 2 weeks and 4 weeks compared to plasma-control (untreated) grafts. More importantly, we observed a more complete endothelialization of the lumina] surface with an aligned, well-organized monolayer of endothelial cells, as well as more extensive graft integration in terms of vascularization and cell infiltration from the surrounding tissue. This work demonstrates the feasibility of electrospinning PCU as synthetic elastic material to fabricate nanofibrous vascular grafts, as well as the potential to endow desired functionalization to the graft surface via plasma treatment for the conjugation of heparin or other bioactive molecules.Statement of SignificanceVascular occlusion remains the leading cause of death all over the world, despite advances made in balloon angioplasty and conventional surgical intervention. Currently, autografts are the gold-standard grafts used to treat vascular occlusive disease. However, many patients with vascular occlusive disease do not have autologous vascular graft available. Therefore, there is a widely recognized need for a readily available, functional, small-diameter vascular graft (inner diameter of <6 mm). This work addresses this critical need by developing a method of antithrombogenic modification of synthetic grafts. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Heparinization and Hybridization of Electrospun Tubular Graft for Improved Endothelialization and Anticoagulation.

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

Co-immobilization of ACH11 Antithrombotic Peptide and CAG Cell-Adhesive Peptide Onto Vascular Grafts for Improved Hemocompatibility and Endothelialization.

Controllable Synthesis of Biomimetic Nano/submicro-Fibrous Tubes for Potential Small-Diameter Vascular Grafts

End-point Immobilization of Heparin on Plasma-Treated Surface of Electrospun Polycarbonate-Urethane Vascular Graft.

Effect of Sustained Heparin Release from PCL/chitosan Hybrid Small-Diameter Vascular Grafts on Anti-Thrombogenic Property and Endothelialization.

Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

Composite Vascular Grafts with High Cell Infiltration by Co-Electrospinning

Biomimetic Tubular Scaffold with Heparin Conjugation for Rapid Degradation in in Situ Regeneration of a Small Diameter Neoartery.

An Integrated Micro-nano-fibrous Bilayered Small-Diameter Vascular Graft Simultaneously Supporting Endothelial and Smooth Muscle Cells

Construction of Enzyme-Laden Vascular Scaffolds Based on Hyaluronic Acid Oligosaccharides-Modified Collagen Nanofibers for Antithrombosis and In-Situ Endothelialization of Tissue-Engineered Blood Vessels.

Untangling the co-effects of oriented nanotopography and sustained anticoagulation in a biomimetic intima on neovessel remodeling.

Hydrogen Sulfide Releasing and Carboxybetaine Modified Vascular Graft with Enhanced Anticoagulant, Anticalcification, and Pro-Endothelialization Properties

A Method for Preparation of an Internal Layer of Artificial Vascular Graft Co-Modified with Salvianolic Acid B and Heparin

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

Nanofibers with Homogeneous Heparin Distribution and Protracted Release Profile for Vascular Tissue Engineering

Catechol-Modified Biomolecules in Layer-By-Layer Assembly: A Fishing Net-Like Model to Enhance Stability and Long-Term Performance

A bi-layered tubular scaffold for effective anti-coagulant in vascular tissue engineering

Biomimetic Vascular Grafts with Circumferentially and Axially Oriented Microporous Structures for Native Blood Vessel Regeneration

Preparation and in Vivo Evaluation of Surface Heparinized Small Diameter Tissue Engineered Vascular Scaffolds of Poly(ε-Caprolactone) Embedded with Collagen Suture.

Biofunctionalized Electrospun PCL-PIBMD/SF Vascular Grafts with PEG and Cell-Adhesive Peptides for Endothelialization